APA (7th ed.) Citation

Anthony, D., Sibson, N., Losey, P., Piani, D., & Leppert, D. (2009). Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis.

Chicago Style (17th ed.) Citation

Anthony, D., N. Sibson, P. Losey, D. Piani, and D. Leppert. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.

MLA (9th ed.) Citation

Anthony, D., et al. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.